Business Segments · Goodwill acquired
Cardiovascular — Goodwill acquired
Boston Scientific Cardiovascular — Goodwill acquired decreased by 100.0% to $0 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $205M to $0. Over 3 years (FY 2021 to FY 2025), Cardiovascular — Goodwill acquired shows a downward trend with a -16.3% CAGR.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2014
Last reportedQ1 2026May 1, 2026
Rolls up toGoodwill Additions
How to read this metric
Higher values indicate aggressive inorganic expansion and investment in new cardiovascular technologies.
Detailed definition
Reflects the value of goodwill added to the Cardiovascular segment balance sheet during the current reporting period due...
Peer comparison
Standard acquisition accounting metric found in segment disclosures for acquisitive healthcare firms.
Metric ID:
bsx_segment_cardiovascular_goodwill_acquiredHistorical Data
18 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0 | $0 | $1.52B | $988M | $1M | $41M | $0 | $336M | $4M | $0 | $46M | $563M | $6M | $205M | $648M | $0 | $37M | $0 |
| QoQ Change | — | — | — | -35.0% | -99.9% | >999% | -100.0% | — | -98.8% | -100.0% | — | >999% | -98.9% | >999% | +216.1% | -100.0% | — | -100.0% |
| YoY Change | — | — | — | — | — | — | -100.0% | -66.0% | +300.0% | -100.0% | >999% | — | — | — | >999% | -100.0% | +516.7% | -100.0% |
Range$0 – $1.52B
Avg YoY Growth+301.0%
Median YoY Growth-66.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Boston Scientific's cardiovascular — goodwill acquired?
- Boston Scientific (BSX) reported cardiovascular — goodwill acquired of $0 in Q1 2026.
- How has Boston Scientific's cardiovascular — goodwill acquired changed year-over-year?
- Boston Scientific's cardiovascular — goodwill acquired decreased by 100.0% year-over-year, from $205M to $0.
- What is the long-term trend for Boston Scientific's cardiovascular — goodwill acquired?
- Over 3 years (2021 to 2025), Boston Scientific's cardiovascular — goodwill acquired has grown at a -16.3% compound annual growth rate (CAGR), from $1.52B to $890M.
- What does cardiovascular — goodwill acquired mean?
- The amount of new goodwill added to the Cardiovascular segment from recent acquisitions.